Article Activism, M&A Regeneron shareholders to vote on pharma patent proposal Apr 26, 2023By Ben Maiden
Article Shareholder targeting & ID What every IRO should know about engaging large institutional holders Aug 16, 2022By Jane Storero
Article Reporting Report highlights evolving ESG disclosure in proxy statements Oct 08, 2019By Ben Maiden